Department of Biostatistics and Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA 98195, USA.
Epidemiology. 2011 Nov;22(6):805-12. doi: 10.1097/EDE.0b013e31823035fb.
Epidemiologic methods are well established for investigating the association of a predictor of interest and disease status in the presence of covariates also associated with disease. There is less consensus on how to handle covariates when the goal is to evaluate the increment in prediction performance gained by a new marker when a set of predictors already exists. We distinguish between adjusting for covariates and joint modeling of disease risk in this context. We show that adjustment and joint modeling are distinct concepts, and we describe the specific conditions where they are the same. We also discuss the concept of interaction among variables and describe a notion of interaction that is relevant to prediction performance. We conclude with a discussion of the most appropriate methods for evaluating new biomarkers in the presence of existing predictors.
流行病学方法在存在与疾病相关的协变量的情况下,用于研究感兴趣的预测因子与疾病状态之间的关联已得到充分确立。但是,对于当存在一组预测因子时,如何处理协变量以评估新标志物带来的预测性能增益,人们的共识较少。在这种情况下,我们将协变量的调整与疾病风险的联合建模区分开来。我们表明调整和联合建模是不同的概念,并描述了它们相同的具体条件。我们还讨论了变量之间相互作用的概念,并描述了与预测性能相关的相互作用概念。最后,我们讨论了在存在现有预测因子的情况下评估新生物标志物的最合适方法。